Crinetics Pharmaceuticals, Inc. (CRNX) Ownership

$32.33

$0.75 (-2.27%)
Last update: 04:00 PM EST
Day's range
$32.3
Day's range
$33.32

Crinetics Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/12/2025 14.03 M $470.61 M   57.16% 15.07%
VANGUARD GROUP INC 05/09/2025 9.31 M $312.31 M   2.44% 10.00%
BLACKROCK, INC. 05/02/2025 7.66 M $256.80 M   1.88% 8.22%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 6.89 M $231.14 M   -0.85% 7.40%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2025 6.24 M $209.29 M   1.61% 6.70%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 5.11 M $171.47 M   -5.58% 5.49%
FARALLON CAPITAL MANAGEMENT LLC 05/15/2025 4.61 M $154.45 M   13.01% 4.95%
JANUS HENDERSON GROUP PLC 05/15/2025 3.42 M $118.90 M   22.50% 3.68%
STATE STREET CORP 05/15/2025 3.28 M $110.12 M   9.78% 3.53%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 2.19 M $73.50 M   4.39% 2.35%
JENNISON ASSOCIATES LLC 05/05/2025 2.12 M $71.10 M   -21.73% 2.28%
PARADIGM BIOCAPITAL ADVISORS LP 05/15/2025 1.95 M $65.27 M   1.85% 2.09%
SIREN, L.L.C. 05/23/2025 1.69 M $56.64 M   4.91% 1.81%
VESTAL POINT CAPITAL, LP 05/15/2025 1.50 M $50.31 M   100.00% 1.61%
NOVO HOLDINGS A/S 05/15/2025 1.28 M $42.76 M   32.78% 1.37%
PICTET ASSET MANAGEMENT HOLDING SA 05/05/2025 1.05 M $35.12 M   23.46% 1.12%
ORBIMED ADVISORS LLC 05/15/2025 999.00 K $33.51 M   0.00% 1.07%
FRANKLIN RESOURCES INC 05/13/2025 963.28 K $32.31 M   -39.48% 1.03%
GW&K INVESTMENT MANAGEMENT, LLC 05/05/2025 920.02 K $30.86 M   35.47% 0.99%
HOOD RIVER CAPITAL MANAGEMENT LLC 05/15/2025 872.64 K $29.27 M   2.49% 0.94%
NORTHERN TRUST CORP 05/13/2025 857.08 K $28.75 M   -2.58% 0.92%
FIRST LIGHT ASSET MANAGEMENT, LLC 05/15/2025 855.42 K $28.69 M   -3.39% 0.92%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 778.40 K $26.11 M   -72.09% 0.84%
FISHER ASSET MANAGEMENT, LLC 05/14/2025 773.35 K $25.94 M   38.27% 0.83%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 753.53 K $25.27 M   -0.74% 0.81%
AMERICAN CENTURY COMPANIES INC 05/13/2025 719.58 K $24.13 M   50.76% 0.77%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/14/2025 689.27 K $23.12 M   -31.27% 0.74%
BIOIMPACT CAPITAL LLC 05/15/2025 631.96 K $21.20 M   2.42% 0.68%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 05/14/2025 610.84 K $20.49 M   6.04% 0.66%
CORMORANT ASSET MANAGEMENT, LP 05/15/2025 600.00 K $20.12 M   -40.00% 0.64%
05/12/2025 562.94 K $15.86 M   100.00% 0.60%
IKARIAN CAPITAL, LLC 05/15/2025 523.43 K $17.56 M   1.36% 0.56%
SG AMERICAS SECURITIES, LLC 04/15/2025 522.27 K $17.52 M   -3.72% 0.56%
ENSIGN PEAK ADVISORS, INC 05/14/2025 514.81 K $17.27 M   2.41% 0.55%
MORGAN STANLEY 05/15/2025 514.68 K $17.26 M   1.91% 0.55%
GOLDMAN SACHS GROUP INC 05/16/2025 499.59 K $16.76 M   -30.73% 0.54%
CANDRIAM S.C.A. 05/14/2025 488.91 K $16.40 M   100.00% 0.53%
FIERA CAPITAL CORP 05/07/2025 438.34 K $14.70 M   -3.66% 0.47%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 429.06 K $14.39 M   95.45% 0.46%
VOYA INVESTMENT MANAGEMENT LLC 05/15/2025 358.54 K $12.03 M   -7.88% 0.39%
UBS ASSET MANAGEMENT AMERICAS INC 05/19/2025 347.58 K $11.66 M   6.86% 0.37%
BANK OF NEW YORK MELLON CORP 04/29/2025 344.58 K $11.56 M   -0.05% 0.37%
05/06/2025 342.73 K $11.50 M   2.38% 0.37%
UBS GROUP AG 05/13/2025 315.66 K $10.59 M   -55.40% 0.34%
BANK OF AMERICA CORP /DE/ 05/15/2025 304.93 K $10.23 M   29.60% 0.33%
M&G PLC 05/13/2025 281.82 K $9.58 M   100.00% 0.30%
JPMORGAN CHASE & CO 05/12/2025 265.50 K $8.90 M   -1.50% 0.29%
VICTORY CAPITAL MANAGEMENT INC 05/02/2025 251.33 K $8.43 M   -10.70% 0.27%
PRUDENTIAL FINANCIAL INC 05/13/2025 242.88 K $8.28 M   -12.44% 0.26%
ABRDN PLC 05/13/2025 208.06 K $6.98 M   379.52% 0.22%

Crinetics Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 295 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals, Inc.. The most heavily invested institutionals were:

FMR LLC: 14.03 M

VANGUARD GROUP INC: 9.31 M

BlackRock, Inc.: 7.66 M

WELLINGTON MANAGEMENT GROUP LLP: 6.89 M

DRIEHAUS CAPITAL MANAGEMENT LLC: 6.24 M

PRICE T ROWE ASSOCIATES INC /MD/: 5.11 M

109.43% of Crinetics Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 108.44 M shares in the last 24 months. This purchase volume represents approximately $3.51 B in transactions.